Skip to main content
Premium Trial:

Request an Annual Quote

Paracel Closes Down Operations

NEW YORK, Sept. 29 (GenomeWeb News) - Paracel, a Celera Genomics subsidiary, has closed down its operations, the company said yesterday.

 

In a notice posted on its website, the Pasadena, Calif.-based bioinformatics tool provider said that as of Sept. 28, it has discontinued all operations except for ongoing support to its current contract customers.

 

No further information was immediately available from Paracel.

 

Two years ago, GenomeWeb News reported that Paracel's future as a Celera unit was uncertain. The company has been providing genome researchers with bioinformatics hardware systems, including GeneMatcher and BlastMachine.

 

Paracel was founded in 1992 to commercialize data-filtering technology developed by TRW for government applications. Together with researchers from Caltech and Applied Biosystems, the firm programmed the FDF system for genomic data analysis.

The company became a wholly owned subsidiary of Applera after Celera acquired it in a stock-for-stock transaction in June 2000. The company is based in Pasadena, Calif., and has offices in San Jose, Calif., Columbia, Md., and the UK.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.